Michael May
Michael May is President and CEO of the Centre for Commercialization of Regenerative Medicine (CCRM), a Canadian, not-for-profit that develops technologies, launches new companies and catalyzes investment in the field of regenerative medicine, including cell and gene therapy. Prior to CCRM, Michael was the President, and co-founder, of Rimon Therapeutics Ltd., a Toronto-based tissue engineering company developing novel medical polymers that possess drug-like activity.
Appears in 1 Episode
Michael May | Centre for Commercialization of Regenerative Medicine
July 16th 2024 - From the archives, our guest this week is Michael May, President and CEO of the Centre for Commercialization of Regenerative Medicine. Michael is some...
